Downloadable slideset covering key HIV studies presented at IDWeek, Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options
Study 1878: Suppression maintained through Week 48 after switch to BIC/FTC/TAF with M184V/I presented at Glasgow 2018 reported by Clinical Care Options
Focused commentary from Babafemi Taiwo, MBBS, on potential clinical implications of promising early data for HIV capsid inhibitor GS-6207 and NRTTI MK-8591.
Downloadable slides of key HIV studies presented at IDWeek, HIV Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.